메뉴 건너뛰기




Volumn 87, Issue 6, 2010, Pages 645-647

Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CERIVASTATIN; ROFECOXIB; ROSIGLITAZONE;

EID: 77952558872     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.213     Document Type: Short Survey
Times cited : (10)

References (11)
  • 1
    • 77952580577 scopus 로고    scopus 로고
    • 128 S. Ct.
    • Riegel v. Medtronic, 128 S. Ct. 999 (2008).
    • (2008) Medtronic , pp. 999
    • Riegel, V.1
  • 2
    • 77952562844 scopus 로고    scopus 로고
    • U.S.
    • Wyeth v. Levine, 555 U.S. (2009).
    • (2009) Levine , pp. 555
    • Wyeth, V.1
  • 4
    • 77952555851 scopus 로고    scopus 로고
    • no.06-179 (filed August 2007)
    • Riegel v. Medtronic, no.06-179 (filed August 2007).
    • Medtronic
    • Riegel, V.1
  • 5
    • 33846413998 scopus 로고    scopus 로고
    • The role of litigation in defining drug risks
    • Kesselheim, A.S. & Avorn, J. The role of litigation in defining drug risks. JAMA 297, 308-311 (2007).
    • (2007) JAMA , vol.297 , pp. 308-311
    • Kesselheim, A.S.1    Avorn, J.2
  • 6
    • 77952554923 scopus 로고    scopus 로고
    • Glaxo's emails on Avandia reveal concern
    • 14 January
    • Mundy, A. & Favole, J. Glaxo's emails on Avandia reveal concern. Wall Street Journal, 14 January 2009.
    • (2009) Wall Street Journal
    • Mundy, A.1    Favole, J.2
  • 7
    • 77952579644 scopus 로고    scopus 로고
    • Office of New Drugs, US Food and Drug Administration. FDA's drug approval process: up to the challenge? 1 March 2005
    • Kweder, S, Office of New Drugs, US Food and Drug Administration. FDA's drug approval process: up to the challenge? Hearing before the Senate Health, Education, Labor and Pensions Committee, 109th Congress http://frwebgate.access. gpo.gov/cgi-bin/getdoc.cgi?dbname=109-senate- hearings&docid=99-761 (1 March 2005).
    • Hearing before the Senate Health, Education, Labor and Pensions Committee, 109th Congress
    • Kweder, S.1
  • 8
    • 40449140715 scopus 로고    scopus 로고
    • Semper fidelis\consumer protection for patients with implanted medical devices
    • Maisel, W.H. Semper fidelis\consumer protection for patients with implanted medical devices. N. Engl. J. Med. 358, 985-987 (2008).
    • (2008) N. Engl. J. Med. , vol.358 , pp. 985-987
    • Maisel, W.H.1
  • 9
    • 40049109730 scopus 로고    scopus 로고
    • A critical examination of the FDA's efforts to preempt failure-to-warn claims
    • Kessler, D.A. & Vladeck, D.C. A critical examination of the FDA's efforts to preempt failure-to-warn claims. Georgetown Law J. 96, 461-495 (2008).
    • (2008) Georgetown Law J. , vol.96 , pp. 461-495
    • Kessler, D.A.1    Vladeck, D.C.2
  • 10
    • 59749089195 scopus 로고    scopus 로고
    • The Supreme Court, preemption, and malpractice liability
    • Kesselheim, A.S. & Studdert, D.M. The Supreme Court, preemption, and malpractice liability. N. Engl. J. Med. 360, 559-561 (2009).
    • (2009) N. Engl. J. Med. , vol.360 , pp. 559-561
    • Kesselheim, A.S.1    Studdert, D.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.